Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8974
|
| pubmed:dateCreated |
1995-10-3
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
26
|
| pubmed:volume |
346
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
581-2
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7658807-Dose-Response Relationship, Drug,
pubmed-meshheading:7658807-Drug Administration Schedule,
pubmed-meshheading:7658807-Gaucher Disease,
pubmed-meshheading:7658807-Glucosylceramidase,
pubmed-meshheading:7658807-Humans,
pubmed-meshheading:7658807-Liver,
pubmed-meshheading:7658807-Recombinant Proteins
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Treatment regimens in Gaucher's disease.
|
| pubmed:publicationType |
Letter,
Comment
|